- In September 2023, Enovis finalized the acquisition of LimaCorporate S.p.A., a prominent private company in the orthopedic sector. This strategic move aims to enhance Enovis's capabilities in restoring motion through a diverse range of innovative implant solutions. The acquisition positions Enovis as a more formidable player in the global orthopedic market
- In July 2023, Smith+Nephew introduced the REGENTEN bioinductive implant in response to the increasing demand for rotator cuff repair solutions among patients in India. This innovative implant is designed to enhance the healing process and improve outcomes for individuals undergoing rotator cuff surgeries. The launch underscores Smith+Nephew's commitment to addressing the evolving needs of the orthopedic market in the region
- In May 2023, Zimmer Biomet introduced the Persona Osseo Ti KEEL Tibia, a new cement-less knee implant. This innovative product gives surgeons the flexibility to determine whether cement is necessary during the procedure, depending on the patient's bone quality. The launch reflects Zimmer Biomet's dedication to enhancing surgical options and improving patient outcomes in knee replacement surgeries
- In February 2023, CurvaFix unveiled a smaller-diameter CurvaFix IM implant designed to streamline surgical procedures for small-boned patients. This innovative implant offers strong and stable curved fixation, addressing the unique needs of this patient population. The launch highlights CurvaFix's commitment to improving surgical outcomes and enhancing the overall experience for both surgeons and patients
- In April 2022, The Orthopedic Implant Company (OIC) obtained FDA approval for its High-Value Wrist Fracture Plating System. This milestone is expected to enhance OIC's global product portfolio and expand its offerings in the orthopedic market. The approval underscores the company's commitment to delivering innovative solutions for wrist fracture treatment
Frequently Asked Questions
The market is segmented based on Segmentation, By Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Orthobiologics, Trauma, and Craniomaxillofacial Implants, and Others), Biomaterial (Ceramics Biomaterials, Metallic Biomaterials, Polymeric Biomaterials, and Natural Biomaterials Constipation), Procedure (Open Surgery, Minimally Invasive Surgery (MIS), and Others), Device Type (Internal Fixation Devices, and External Fixation Devices), Application (Neck Fracture, Spine Fracture, Hip Replacement, Shoulder Replacement, and Others), End User (Hospitals, Orthopedic Clinics, Home Cares, and Others) – Industry Trends and Forecast to 2031
.
The Global Orthopedic Implants Market size was valued at USD 50.43 USD Million in 2023.
The Global Orthopedic Implants Market is projected to grow at a CAGR of 5.8% during the forecast period of 2024 to 2031.
The major players operating in the market include , CONMED Corporation , Wright Medical Group N.V. , Stryker , Medtronic , Smith+Nephew , Integra LifeSciences , B. Braun Melsungen AG , Arthrex , Baxter , Medical Device Business Services , Globus Medical , NuVasive , Flexicare Medical Limited , BioTek Instruments , Narang Medical Limited , Auxein Medical , Uteshiya Medicare .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
